0001209191-19-014933.txt : 20190301 0001209191-19-014933.hdr.sgml : 20190301 20190301160240 ACCESSION NUMBER: 0001209191-19-014933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190227 FILED AS OF DATE: 20190301 DATE AS OF CHANGE: 20190301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Biller Scott CENTRAL INDEX KEY: 0001581956 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 19649187 MAIL ADDRESS: STREET 1: C/O AGIOS PHARMACEUTICALS, INC. STREET 2: 38 SIDNEY STREET, 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-27 0 0001439222 AGIOS PHARMACEUTICALS INC AGIO 0001581956 Biller Scott C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Scientific Officer Common stock 2019-02-27 4 M 0 1766 0.47 A 28277 D Common stock 2019-02-27 4 M 0 4154 9.05 A 32431 D Common stock 2019-02-27 4 M 0 3080 31.64 A 35511 D Common stock 2019-02-27 4 S 0 9000 65.00 D 26511 D Common stock 53059 I See footnote Stock option (right to buy) 0.47 2019-02-27 4 M 0 1766 0.00 D 2020-12-06 Common stock 1766 0 D Stock option (right to buy) 9.05 2019-02-27 4 M 0 4154 0.00 D 2023-04-30 Common stock 4154 0 D Stock option (right to buy) 31.64 2019-02-27 4 M 0 3080 0.00 D 2024-03-04 Common stock 3080 11782 D This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Shares held by a spousal lifetime access trust, of which the reporting person's wife is the trustee. This option was granted on December 7, 2010. The shares underlying this option vested as to 25% of the shares upon the achievement of a performance milestone, and as to the remaining 75% in 36 equal monthly installments thereafter. The performance criteria was met on June 23, 2015. This option was originally granted on April 30, 2013 for the purchase of 68,181 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 34,091 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 34,090 shares. This option was granted on March 5, 2014. The shares underlying this option vest as to 25% of the shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. /s/ William Cook, as Attorney-in-fact for Scott Biller 2019-03-01